Matthew D. Hellmann

Also affiliated with AstraZeneca (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.8Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Papers

Driven by 66 papers — median percentile 62. Top paper: “Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status”.

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.10.013

N/A

8.9DataRank · unranked

377 citations

Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong +28 more

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0047

N/A

7.6DataRank · unranked

340 citations

Jia Luo, Song Wu, Han Si, Chen Gao, Wenjing Xu +10 more

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.016

N/A

5.4DataRank · unranked

178 citations

Julie George, Taofeek K. Owonikoko, Anton Berns, Élisabeth Brambilla, Lauren A. Byers +42 more

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of 89Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262485

N/A

3.7DataRank · unranked

124 citations

Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn +10 more

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

Cancer Cell(2023)10.1016/j.ccell.2023.03.009

N/A

3.3DataRank · unranked

147 citations

Matthew D. Hellmann, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +28 more

Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child

Nature Medicine(2021)10.1038/s41591-021-01388-5

N/A

2.7DataRank · unranked

113 citations

Rui Yang, Caner Aytekin, David Langlais, Mathieu Bourgey, Taushif Khan +50 more

Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.05.008

N/A

2.4DataRank · unranked

89 citations

David Balli, W. Victoria Lai, Allison L. Richards, Evelyn M. Nguyen, Jacklynn V. Egger +8 more

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Science(2018)10.1126/science.aan3706

N/A

1.3DataRank · unranked

5316 citations

Emmanuelle Le Chatelier, Lisa Derosa, Connie P. M. Duong, Maryam Tidjani Alou, Romain Daillère +48 more

The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0580

Top 16%

1.3DataRank

Top 16%36 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +24 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Acquired Resistance to Immune Checkpoint Inhibitors

Cancer Cell(2020)10.1016/j.ccell.2020.03.017

N/A

1.0DataRank · unranked

887 citations

Matthew D. Hellmann, Adam J. Schoenfeld

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Nature(2021)10.1038/s41586-021-03752-4

N/A

0.948DataRank · unranked

555 citations

Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia, Boyang Zhang, Emily Han-Chung Hsiue +50 more

Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer

Nature Cancer(2022)10.1038/s43018-022-00416-8

N/A

0.888DataRank · unranked

372 citations

Jia Luo, Andrew Aukerman, Jacklynn V. Egger, Christopher J. Fong, Natally Horvat +16 more

COVID-19 in patients with lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.06.007

N/A

0.840DataRank · unranked

270 citations

Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chai Bandlamudi +26 more

Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0596

N/A

0.823DataRank · unranked

241 citations

Hira Rizvi, Jacklynn V. Egger, Isabel R. Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann +1 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0.792DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors

Cancer Cell(2024)10.1016/j.ccell.2024.05.025

N/A

0.790DataRank · unranked

193 citations

Edison Y. Chiu, Aurora Scrivo, Paul Zumbo, Asim Dave, Doron Betel +7 more

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Cancer Cell(2024)10.1016/j.ccell.2023.12.013

N/A

0.788DataRank · unranked

190 citations

Adam J. Schoenfeld, Darwin Ye, George Fromm, Hira Rizvi, Xiang H.-F. Zhang +28 more

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001282

N/A

0.768DataRank · unranked

166 citations

Valsamo Anagnostou, Tricia R. Cottrell, Kellie N. Smith, Franco Verde, Marianna Zahurak +27 more

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004440

N/A

0.729DataRank · unranked

128 citations

Venkata Nagineni, Arvind Ravi, Ila Datar, Mari Mino–Kenudson, Germán Corredor +11 more

Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C–Mutant Non–Small Cell Lung Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4023

N/A

0.725DataRank · unranked

125 citations

Hira Rizvi, Andrew J. Plodkowski, Matthew D. Hellmann, Andrea Knežević, Glenn Heller +8 more

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3305

N/A

0.725DataRank · unranked

125 citations

Pasi A. Jänne, Mateusz Opyrchal, Navid Hafez, Luis E. Raez, Dmitry I. Gabrilovich +15 more

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3418

N/A

0.723DataRank · unranked

123 citations

Barzin Y. Nabet, Hira Rizvi, Aadel A. Chaudhuri, Daniel K. Wells, Mark Dunphy +30 more

Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0921

N/A

0.672DataRank · unranked

87 citations

Victoria Martucci, Zoe Quandt, Stefan Groha, Megan H. Murray, Christine M. Lovly +16 more

Fundamental immune–oncogenicity trade-offs define driver mutation fitness

Nature(2022)10.1038/s41586-022-04696-z

N/A

0.663DataRank · unranked

82 citations

Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin C. de Andrade, Dean F. Bajorin +25 more

Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0419

N/A

0.635DataRank · unranked

68 citations

Anh Tuan Luu, Jia Luo, Hira Rizvi, Andrew J. Plodkowski, Mustafa Sakhi +11 more

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

Cancer Medicine(2020)10.1002/cam4.3113

N/A

0.626DataRank · unranked

64 citations

Maria Thor, Annemarie F. Shepherd, Michael Offin, Andrew Jackson, Abraham J. Wu +9 more

Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001007

N/A

0.614DataRank · unranked

59 citations

Biagio Ricciuti, E. Jimenez-Aguilar, Fangxin Hong, Zihan Wei, Mizuki Nishino +10 more

Deciphering radiological stable disease to immune checkpoint inhibitors

Annals of Oncology(2022)10.1016/j.annonc.2022.04.450

N/A

0.590DataRank · unranked

50 citations

Song Wu, Hira Rizvi, Q. Zhang, Jacklynn V. Egger, Juan C. Osorio +14 more

Protein-altering germline mutations implicate novel genes related to lung cancer development

Nature Communications(2020)10.1038/s41467-020-15905-6

N/A

0.587DataRank · unranked

49 citations

Semanti Mukherjee, Maria Teresa Landi, Yohan Bossé, Philippe Joubert, Dakai Zhu +95 more

Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0498

N/A

0.564DataRank · unranked

42 citations

Nicholas R. Waters, Natalie Smith, Anqi Dai, John Slingerland, Nathan Aleynick +24 more

Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.01488

N/A

0.542DataRank · unranked

36 citations

Meagan Montesion, Smruthy Sivakumar, Caryn Hale, Anita S. Bowman, Ayyüce Begüm Bektaş +29 more

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1207

N/A

0.542DataRank · unranked

36 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Hira Rizvi, Arielle Elkrief +23 more

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1287

N/A

0.524DataRank · unranked

32 citations

Chaitanya Bandlamudi, Matthew D. Hellmann, Yelena Kemel, Esther Drill, Hira Rizvi +32 more

Regional and clonal T cell dynamics at single cell resolution in immune checkpoint blockade

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.27.461389

Top 38%

0.510DataRank

Top 38%6 citations

Andrew Chow, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +21 more

Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer

The Journal of Experimental Medicine(2024)10.1084/jem.20231106

N/A

0.494DataRank · unranked

26 citations

Katherine Hastings, Jungmin Choi, Isabelle Sirois, Arvind Ravi, Francisco Expósito +14 more

Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2022.12.019

N/A

0.489DataRank · unranked

25 citations

Matthew Fronheiser, Naiyer A. Rizvi, Matthew D. Hellmann, Sabine Maier, Wendy Hayes +7 more

Acquired resistance to PD-1 blockade in NSCLC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9621

N/A

0.425DataRank · unranked

16 citations

Hira Rizvi, Danish Memon, Jia Luo, Isabel R. Preeshagul, Jennifer L. Sauter +5 more

The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant Tumors

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.04.019

N/A

0.425DataRank · unranked

16 citations

Michael Offin, Annemarie F. Shepherd, Charles B. Simone, Daphna Y. Gelblum, Abraham J. Wu +6 more

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006994

N/A

0.416DataRank · unranked

15 citations

Joao V. Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R. Preeshagul +16 more

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer

The Oncologist(2023)10.1093/oncolo/oyad197

N/A

0.385DataRank · unranked

12 citations

Biagio Ricciuti, Joao V. Alessi, Teng Fei, Hannah L. Kalvin, Jacklynn V. Egger +16 more

Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2990

N/A

0.312DataRank · unranked

7 citations

Rohit Thummalapalli, Stephanie Alden, Biagio Ricciuti, Joao V. Alessi, Arielle Elkrief +18 more

Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9067

N/A

0.269DataRank · unranked

5 citations

Angela B. Hui, Jacob J. Chabon, Everett J. Moding, Emily S. Lebow, José de Arimateia Batista Araújo-Filho +15 more

Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2574

N/A

0.241DataRank · unranked

4 citations

Christopher A. Desjardins, Paul A. Giardina, Kankana Bardhan, Swarna Pandian, Keith Halley +14 more

CD39 Identifies Tumor-Reactive CD8 T cells in Patients With Lung Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.24.477554

N/A

0.240DataRank · unranked

3 citations

Fathema Uddin, Levi Mangarin, Hira Rizvi, Anton Dobrin, Sam E. Tischfield +31 more

Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9092

N/A

0.233DataRank · unranked

2 citations

Jason Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern +8 more

Fast, light, and scalable: harnessing data-mined line annotations for automated tumor segmentation on brain MRI

European Radiology(2023)10.1007/s00330-023-09583-3

N/A

0.165DataRank · unranked

2 citations

Vivek Yadav, Krishna Nand Keshava Murthy, Pierre Elnajjar, Hao-Hsin Shih, Prashanth Kumar Panyam +39 more

Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancer

Lung Cancer(2021)10.1016/j.lungcan.2021.08.020

N/A

0DataRank · unranked

5 citations

Andrew Pagano, Andrew J. Plodkowski, Jeffrey Girshman, Matthew D. Hellmann, Hira Rizvi +6 more

Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab

Radiotherapy and Oncology(2021)10.1016/j.radonc.2021.12.016

N/A

0DataRank · unranked

21 citations

Annemarie F. Shepherd, Isabel R. Preeshagul, Michael Offin, Daphna Y. Gelblum, Abraham J. Wu +9 more

Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100197

N/A

0DataRank · unranked

25 citations

Michael Offin, Annemarie F. Shepherd, Matthew D. Hellmann, Daniel R. Gomez, Jamie E. Chaft +2 more

Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2457

N/A

0DataRank · unranked

14 citations

Yvonne Wang, Gang Peng, Jianlei Gu, Mari Mino–Kenudson, Jonathan W. Riess +6 more

Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.06.024

N/A

0DataRank · unranked

109 citations

Jason Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern +8 more

Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.03.547423

N/A

0DataRank · unranked

5 citations

Aurora Scrivo, Paul Zumbo, Asim Dave, Doron Betel, Matthew D. Hellmann +4 more

Data from Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6530652.v1

N/A

0DataRank · unranked

0 citations

Victoria Martucci, Zoe Quandt, Stefan Groha, Megan H. Murray, Christine M. Lovly +16 more

Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6742700.v1

Top 100%

0DataRank

Top 100%0 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +23 more

Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6742700

Top 100%

0DataRank

Top 100%0 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +23 more

TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion

The Journal of Experimental Medicine(2021)10.1084/jem.20201966

N/A

0DataRank · unranked

155 citations

Paul Zumbo, Gabriel Espinosa-Carrasco, Laura Menocal, Friederike Dündar, Sandra E. Carson +17 more

Phase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas

UNC Libraries(2020)10.17615/d2gv-4708

N/A

0DataRank · unranked

0 citations

Matthew D. Hellmann, Alex Lash, Mary Shaw, Lauren J. Rogak, Pietanza +9 more

Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors

Annals of Oncology(2020)10.1016/j.annonc.2020.09.016

N/A

0DataRank · unranked

52 citations

Jason Beattie, Maria Thor, Michael Offin, Annemarie F. Shepherd, Daphna Y. Gelblum +7 more

Computational biomarker predicts lung ICI response via deep learning-driven hierarchical spatial modelling from H&E

Research Square(2022)10.21203/rs.3.rs-1251762/v1

N/A

0DataRank · unranked

8 citations

Chad Vanderbilt, Chao Feng, David Joon Ho, Gabrielle Campanella, Jacklynn V. Egger +7 more

Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab

Radiotherapy and Oncology(2020)10.1016/j.radonc.2020.04.047

N/A

0DataRank · unranked

56 citations

Narek Shaverdian, Andreas Rimner, Stephanie Lobaugh, Annemarie F. Shepherd, Charles B. Simone +10 more

Efficacy of PD-(L)1 blockade monotherapy compared to PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

medRxiv(2022)10.1101/2022.12.05.22283131

N/A

0DataRank · unranked

0 citations

Joao M. Victor Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R. Preeshagul +16 more

Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer

Frontiers in Immunology(2022)10.3389/fimmu.2022.961105

N/A

0DataRank · unranked

1 citations

Yuexin Xu, Andrea Towlerton, Marcin Kowanetz, Priti S. Hegde, Martine Darwish +13 more

Semisupervised Training of a Brain MRI Tumor Detection Model Using Mined Annotations

Radiology(2022)10.1148/radiol.210817

N/A

0DataRank · unranked

12 citations

Vivek Yadav, Julie Kim, Ye Rim Choi, David Gutman, Jonathan T. Yang +40 more

Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions

The Journal of Experimental Medicine(2022)10.1084/jem.20212169

N/A

0DataRank · unranked

49 citations

Andrew Chow, Levi Mangarin, Heng Pan, Jiajia Zhang, Nicholas Ceglia +21 more

Matthew D. Hellmann

Indexed papers

Top data-sharing exemplar

Papers